How Long Do SI Joint Injections Last?

A corticosteroid injection into the sacroiliac (SI) joint typically provides meaningful pain relief for somewhere between a few weeks and six months, with most people noticing the effect start to fade around the two- to three-month mark. That range is wide because the answer depends on what is causing your SI joint pain, what gets injected, exactly where the needle goes, and a handful of personal factors like your weight and activity level. Understanding where you fall in that range, and what options exist when injections wear off too quickly, is where the real practical value lies.

What a Steroid Injection Actually Delivers

The most common SI joint injection combines a corticosteroid (to reduce inflammation) with a local anesthetic (for immediate but temporary numbing). The anesthetic gives you a few hours of relief right away, which also helps confirm the SI joint as the pain source. The steroid takes a few days to kick in and provides the longer-lasting benefit. A recent multisociety consensus recommends about 40 mg of methylprednisolone or triamcinolone per SI joint as a reasonable dose, though no formal dose-response studies exist to pin down an ideal amount.¹

In terms of duration, guidelines from several major pain societies characterize corticosteroid injections as providing “short-term pain relief from a few weeks to a few months.”² But individual studies paint a more detailed picture. One prospective study using CT-guided injections in patients with active sacroiliitis found that pain scores dropped significantly at one week and held relatively steady through one month. By three months, about 55% of patients still had substantial relief (defined as at least a four-point drop on a ten-point pain scale). At six months, that number slipped to 45%.³

Another prospective study tracking patients with SI joint dysfunction after a combined triamcinolone-and-ropivacaine injection found that pain scores improved from baseline by about 40% at four weeks and stayed at that level through eight weeks, with a slight additional improvement at six months.⁴ In open studies of patients with spondyloarthritis (an inflammatory condition that commonly affects the SI joint), good responses were reported in more than 80% of cases, with a mean duration of improvement exceeding eight months.⁵ That longer duration likely reflects the fact that inflammatory conditions tend to respond better to steroids than degenerative or mechanical problems do.

Why Duration Varies So Much From Person to Person

A few weeks versus eight months is a huge spread, and it is not random. The biggest single driver of how long your injection lasts is the underlying cause of the pain. Inflammatory conditions like spondyloarthritis or active sacroiliitis, where the joint lining is swollen and producing inflammatory chemicals, tend to respond more robustly and for longer. That makes intuitive sense: a steroid is an anti-inflammatory drug, so it works best when inflammation is the primary problem. Research on intra-articular corticosteroids across different joints confirms this pattern. In conditions with high levels of inflammation, the response rate is substantially better than in joints where the issue is mostly structural wear.⁶

Beyond the diagnosis, certain patient characteristics predict who will and who will not get a good result. A prospective study of diagnostic-block-confirmed SI joint patients found that obesity and pain that radiates below the knee were the strongest independent predictors of a failed pain response at three months.⁷ Manual labor and greater pre-injection disability scores also trended toward worse outcomes. Separately, older age has been associated with a higher likelihood of having SI joint pathology that responds to injection: in one study, the average age of people with a positive response to diagnostic SI joint blocks was about 53, compared to 47 in those with a negative result.⁸

None of this means an injection won’t help if you’re younger or heavier, but it does mean that if your first injection wears off quickly, your provider should look at these factors rather than simply repeating the same procedure and hoping for a different result.

Where the Needle Goes Makes a Difference

The SI joint is an anatomically tricky target. It is deep, irregularly shaped, and surrounded by a dense web of ligaments that are themselves loaded with pain-sensing nerves. That last detail matters, because a meaningful share of SI joint pain may be coming not from inside the joint but from the periarticular structures, the ligaments, muscles, and tissue around it.

One study directly compared periarticular and intra-articular lidocaine injections and found a striking difference: the periarticular injection was effective in all 25 patients, while the intra-articular injection worked in only 9 of 25. When the 16 non-responders received a follow-up periarticular injection, all of them improved.⁹ A multicenter study using fluoroscopy-guided injections found that periarticular injections were statistically superior at every time point measured, from immediately post-injection through three months.¹⁰ Another study noted that both approaches provided significant immediate and one-week pain relief, with no statistically significant difference between them.¹¹

The takeaway is that an injection that only enters the joint cavity may miss the real pain generator in some people. If you’ve had an intra-articular injection that didn’t help much, it doesn’t necessarily mean injections are useless for you; a periarticular approach might reach the structures actually causing your symptoms.

Imaging guidance also plays a role. Most SI joint injections today are done under fluoroscopy (real-time X-ray) or ultrasound. One randomized trial found that fluoroscopy-guided injections had a higher accuracy rate (about 98%) compared to ultrasound-guided injections (about 87%), though both produced similar improvements in pain and disability scores at 12 weeks.¹² A separate trial comparing the two imaging methods also found no significant difference in pain scores at one month, with both groups showing meaningful reduction from baseline.¹³ In practical terms, either method is reasonable, but the precision of fluoroscopy gives a slight technical edge for getting the needle exactly where it should be.

PRP and Prolotherapy as Longer-Lasting Alternatives

Because corticosteroid injections have a limited window of relief, there is growing interest in biologic injectables that might last longer. Platelet-rich plasma (PRP), made from a concentrated sample of your own blood, is the most studied alternative. The idea is that PRP delivers growth factors that promote healing in the joint tissues rather than just damping down inflammation temporarily.

The research here is genuinely mixed, and it is worth being upfront about that. One randomized trial of ultrasound-guided SI joint injections found that PRP maintained a 90% efficacy rate at three months, while steroid efficacy had dropped to just 25%. PRP patients also showed continued improvements in disability and quality-of-life scores over that period, whereas the steroid group’s improvements peaked around four weeks and then faded.¹⁴ A systematic review covering multiple studies concluded that PRP generally shows greater and longer-lasting benefits than corticosteroids, with a lower need for repeat procedures.¹⁵

But a double-blinded randomized trial published in Pain Medicine found essentially the opposite: steroid injections produced lower pain scores than PRP at one, three, and six months, with significantly more responders in the steroid group at one and three months. By six months, the difference between groups was no longer statistically significant.¹⁶ The conflicting results probably reflect differences in how PRP was prepared (there is no standardized formula), patient populations, and follow-up methods. At this point, PRP looks promising but is not clearly superior to steroids in all studies, and it tends to cost more since most insurance plans consider it experimental.

Prolotherapy, which involves injecting an irritant solution (typically dextrose) to provoke a healing response, has a smaller evidence base for SI joint pain. One randomized controlled trial followed patients for 15 months and found that roughly 59% of the prolotherapy group achieved at least 50% pain relief, compared to only about 10% in the steroid group, a statistically significant difference.¹⁷ If that result holds up in larger studies, prolotherapy would represent a major improvement in durability over steroids, but a single trial is not enough to draw firm conclusions.

Radiofrequency Ablation for Longer Relief

When injections confirm the SI joint as the pain source but relief doesn’t last long enough, radiofrequency ablation (RFA) is the standard next step. RFA uses heat (delivered through a needle electrode) to disrupt the nerves that carry pain signals from the SI joint. It doesn’t fix the joint itself, but it blocks the pain signal, sometimes for considerably longer than a steroid injection.

A meta-analysis of RFA for SI joint pain found pooled success rates of about 62% at three months and 50% at six months.¹⁸ A study comparing cooled and traditional RFA techniques found that both provided more than 50% pain reduction for three to six months in a majority of patients.¹⁹ The ablated nerves do regenerate over time, which means relief is not permanent, but repeat procedures are an option. One study found that a repeat cooled RFA procedure provided an average of nine months of relief, compared to about five and a half months after the initial procedure, suggesting the second round may actually last longer.²⁰

RFA is not a casual step up from injection, it requires its own set of diagnostic blocks first, and recovery takes a bit longer. But for people who get good short-term relief from steroid injections and just need something more durable, it fills a useful middle ground between injections and surgery.

Safety and How Often Injections Can Be Repeated

SI joint injections are generally safe, but they are not risk-free, and there is a ceiling on how often you should have them. The most common side effects in one prospective survey were injection-site soreness (about 13% of cases), temporary worsening of pain (about 5%), and facial flushing or sweating (about 2%). Vasovagal reactions (feeling faint) occurred in about 2% of procedures.²¹ These are generally short-lived.

The more meaningful concerns are systemic. Repeated corticosteroid injections can raise blood glucose levels (a real issue for people with diabetes), suppress the adrenal glands, reduce bone mineral density, and potentially damage cartilage in the injected joint over time.² Most providers limit steroid injections to three or four per joint per year, though there is no universally agreed-upon hard cap. If you find yourself needing injections every two months to stay functional, the conversation should shift toward a longer-lasting intervention rather than simply continuing to inject steroids.

Using Injections as Part of a Bigger Plan

One pattern worth recognizing: the people who get the most mileage out of SI joint injections tend to use the pain-free window to do something active about their condition. Physical therapy targeting the muscles that stabilize the pelvis (especially the glutes and deep core muscles) can address the mechanical factors that stress the SI joint. The injection buys you a window where the exercises don’t hurt as much, and the exercises buy you longer-lasting stability that the injection cannot provide on its own. One long-term follow-up study found that patients who received an average of about two therapeutic injections and engaged in a rehabilitation program showed significant improvements in both disability and pain scores at nearly two years of follow-up.²²

A cost-effectiveness analysis of CT-guided SI joint injections concluded that the procedure falls well below the standard cost-per-quality-adjusted-life-year threshold, meaning it is strongly cost-effective, both for pain improvement and for gains in daily functioning.²³ The value argument is strongest when the injection serves as a stepping stone, confirming the diagnosis and enabling rehabilitation, rather than a standalone repeated treatment.

When the Conversation Moves to Surgery

For people who have confirmed SI joint pain and have been through injections, physical therapy, and possibly radiofrequency ablation without lasting improvement, minimally invasive SI joint fusion is an option. This is a fundamentally different approach: rather than managing symptoms, it aims to eliminate motion in the joint itself. A randomized controlled trial comparing minimally invasive fusion to continued non-surgical management found that the surgery group had a mean pain improvement of about 55 points on a 100-point scale at two years, with more than 80% achieving what the researchers classified as clinical improvement or substantial clinical benefit. In the non-surgical group, fewer than 10% reached that threshold with conservative care alone.²⁴ A broader review of the literature confirmed significant improvement in low back pain at six months and two years in surgical patients, along with a 22% decrease in opioid use at two years.²⁵

Surgery carries its own risks and a longer recovery period, and not everyone is a candidate. But the two-year durability data illustrates an important point: people sometimes frame the question as “how long will my injection last?” when the more useful question is “what is the right treatment for the stage I’m at?” An injection that lasts three months is not a failure if it confirms the diagnosis and lets you start rehab. It becomes a failure only if it turns into a revolving door with no broader plan. The role of the injection is clearest when you and your provider agree on what comes next if the relief fades.